Document is current
Any future updates will be listed below
-
Authors
Diks, Annieck M. http://orcid.org/0000-0001-9941-805X
Teodosio, Cristina
de Mooij, Bas
Groenland, Rick J.
Naber, Brigitta A. E.
de Laat, Inge F.
Vloemans, Sandra A.
Rohde, Susan
de Jonge, Marien I.
Lorenz, Linda
Horsten, Debbie
van Dongen, Jacques J. M.
Berkowska, Magdalena A.
Holstege, Henne
-
Funding
Funding for this research was provided by:
ZonMw (#73305095007)
Health Holland (#LSHM20106)
HorstingStuit Foundation, the Hans und Ilse Breuer Foundation and Stichting VUmc Fund
H2020 Marie Skłodowska-Curie Actions (101034371)
- License Information
-
More Information
Article History
Received: 8 August 2022
Accepted: 14 February 2023
First Online: 20 April 2023
Declarations
:
: In this study, we selected 36 individuals from the 100 plus study cohort, as previously described by Holstege et al (METC number: 2016.440, approved by the Medical Ethics Committee of the VU University Medical Center, Amsterdam, the Netherlands). Informed consent was obtained from each study participant.
: Not applicable.
: AMD, CT, JJMvD and MAB report inventorship of the patent “Means and methods for multiparameter cytometry-based leukocyte subsetting” (NL2844751, PCT/NL2020/050688, filing date 5 November 2019), owned by the EuroFlow Consortium. In addition, JJMvD reports to be chairman of the EuroFlow scientific foundation, which receives royalties from licensed patents, which are collectively owned by the participants of the EuroFlow Foundation. These royalties are exclusively used for continuation of the EuroFlow collaboration and sustainability of the EuroFlow consortium. JJMvD reports an Educational Services Agreement from BD Biosciences (San José, CA) and a Scientific Advisor Agreement with Cytognos; all related fees and honoraria are for the Immunology department at Leiden University Medical Center. All other authors declare they have no competing interests.
